NCT06461702View on ClinicalTrials.gov

Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
Familial Hypercholesterolemia
Interventions
DRUG

YOLT-101

The IP is administered intravenously at the predetermined dose.

Trial Locations (1)

233004

RECRUITING

The First Affiliated Hospital of Bengbu Medical College, Bengbu

All Listed Sponsors
lead

The First Affiliated Hospital of Bengbu Medical University

OTHER